8-K: Ascend Wellness Reports Mixed Q4, FY25 Results Amid Expansion

Ascend Wellness Holdings reported Q4 2025 revenue of $120.5 million and full-year revenue of $500.6 million, alongside an expanded Adjusted EBITDA Margin and continued retail footprint growth.

Summary

• Total net revenue for Q4 2025 was $120.5 million, a 3.4% sequential decline from Q3 2025.
• Full-year 2025 total net revenue reached $500.6 million, representing a 10.9% year-over-year decrease from FY 2024.
• Adjusted EBITDA for Q4 2025 was $30.2 million, with an Adjusted EBITDA Margin of 25.1%, a 20-basis point sequential increase.
• Full-year 2025 Adjusted EBITDA was $116.9 million, with an Adjusted EBITDA Margin of 23.4%, an increase from $116.2 million in FY 2024.
• Net loss for Q4 2025 was $48.7 million, including a $17.0 million arbitration settlement expense.
• Net loss for FY 2025 was $118.2 million, compared to $85.0 million in FY 2024.
• The retail footprint expanded to 48 locations with eight new dispensary openings in 2025, and a pipeline for 12 additional locations, targeting 60 by the end of 2026.
• A record 566 SKUs were launched in FY 2025, including two new brands: High Wired and Honor Roll.
• The capital structure was strengthened by fully repaying a $60.0 million term loan and securing $9.3 million in Ohio property financing.
• The normal course issuer bid (NCIB) share buyback program was completed, repurchasing approximately 15.8 million shares at an average price of $0.32 per share.
• Cash and cash equivalents stood at $85.7 million as of December 31, 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed report with significant revenue declines and increased net losses, partially offset by improved Adjusted EBITDA margins and strategic operational advancements. The negative revenue outlook for Q1 2026 indicates continued headwinds.

Positives

• Expanded Adjusted EBITDA Margin to 25.1% in Q4 2025 and 23.4% for FY 2025, demonstrating improved profitability.
• Maintained strong liquidity with $85.7 million in cash and cash equivalents as of December 31, 2025, with no significant near-term debt.
• Retail footprint grew to 48 locations with eight new dispensaries opened in 2025, and a development pipeline for 12 new locations, targeting 60 by the end of 2026.
• Successfully launched a record 566 SKUs in FY 2025, surpassing an initial goal of 550, including two new category-leading brands: High Wired and Honor Roll.
• High Wired quickly emerged as a top performer, ranking second in sales and units in New Jersey, and third across Illinois, Massachusetts, and New Jersey combined in Q4 2025.
• Maintained position among the top three brand houses by both sales and units across Illinois, Massachusetts, and New Jersey combined throughout FY 2025.
• Delivered a fully integrated e-commerce ecosystem, combining a redesigned shopping platform, AI-driven personalization, Ascend Pay functionality, and an enhanced loyalty program.
• Sales through Ascend Pay increased by 49.4% from Q3 2025 to Q4 2025, driven by a 51.5% increase in transactions and a 57.8% rise in units sold.
• Ascenders Club loyalty program total membership grew by 56% with active members increasing by 23.7% sequentially, accounting for 88% of retail transactions.
• Strengthened capital structure by fully repaying the Company's $60.0 million term loan and securing $9.3 million in financing on three Ohio properties at a competitive 8.5% interest rate maturing in September 2030.
• Successfully completed the normal course issuer bid (NCIB) share buyback program, repurchasing approximately 15.8 million shares at an average price of $0.32 per share.
• Exceeded the $30 million annualized cost savings target.
• The $17.0 million arbitration matter was fully resolved in Q1 2026.

Negatives

• Total net revenue declined sequentially in Q4 2025 to $120.5 million from $124.7 million in Q3 2025.
• Total net revenue for FY 2025 declined year-over-year to $500.6 million from $561.6 million in FY 2024, representing a 10.9% decrease.
• Wholesale revenue decreased by 13.1% sequentially in Q4 2025 to $35.5 million and by 15.0% year-over-year in FY 2025 to $161.0 million.
• Net loss for Q4 2025 increased significantly to $48.7 million from $25.8 million in Q3 2025, partly due to a $17.0 million arbitration settlement expense.
• Net loss for FY 2025 increased to $118.2 million from $85.0 million in FY 2024.
• Retail revenue for FY 2025 decreased by 8.8% year-over-year, primarily due to ongoing pricing headwinds and reduced transaction volumes.
• Adjusted Gross Margin declined by 100 basis points sequentially in Q4 2025, impacted by market-wide seasonal discounting.
• General and administrative (G&A) expenses increased sequentially in Q4 2025 to $45.3 million (37.6% of revenue) from $44.9 million (36.0% of revenue).
• The outlook for Q1 2026 expects a lowto mid-single-digit decline in topline revenue due to post-holiday consumer softness, ongoing pricing headwinds, and weather-related closures.
• Higher interest expense contributed to the increased net loss in FY 2025.

Risks

• Ongoing pricing pressures and increased competition in various markets are affecting same-store sales and overall revenue.
• Market-wide seasonal discounting impacted Adjusted Gross Margin in Q4 2025.
• The Q1 2026 outlook anticipates a lowto mid-single-digit decline in topline revenue due to post-holiday consumer softness, ongoing pricing headwinds, and weather-related closures.
• Forward-looking statements are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements to be materially different.
• Preliminary financial metrics are subject to change upon completion of normal quarter-end and year-end accounting procedures, audit adjustments, and other developments.

Future Outlook

For Q1 2026, the Company expects a lowto mid-single-digit decline in topline revenue, reflecting post-holiday consumer softness, ongoing pricing headwinds, and weather-related closures. Despite these pressures, Adjusted EBITDA Margin is expected to remain in the low-20% range, partially offset by the commercialization of higher-margin SKUs, new store openings, and continued increases in direct-to-consumer vertical sales. The Company is on track for its 60-store target by the end of 2026 and will focus on advancing retail densification, enhancing its retail model, and elevating its CPG platform to drive revenue per gram and high-margin sales.

Management Comments

• Sam Brill, CEO: "2025 was a pivotal year for our business, marked by strong progress across our strategic pillars of densification, profitability, and sustainability."
• Sam Brill, CEO: "Our retail footprint expanded with eight new locations, bringing the total to 48 to date and keeping us on track for our 60-store target by the end of 2026."
• Sam Brill, CEO: "Improvements in Adjusted EBITDA margin reflect our continued focus on optimizing product mix while maintaining prudent cost management."
• Frank Perullo, Founder, President & Director: "Our focus on CPG innovation drove meaningful portfolio expansion in 2025, including the launch of two new category-leading brands and a record number of SKUs."
• Frank Perullo, Founder, President & Director: "High Wired quickly emerged as a top performer in the infused flower category, ranking second in total sales and units in New Jersey, and third overall in sales and units across Illinois, Massachusetts, and New Jersey combined as of the end of Q4 2025."
• Roman Nemchenko, CFO: "In 2025, we strengthened our financial flexibility and expanded liquidity to support long-term growth."
• Roman Nemchenko, CFO: "By extending our debt profile and securing mortgage arrangements in Ohio, we established a stable capital foundation for disciplined expansion."
• Roman Nemchenko, CFO: "We entered 2026 with a robust balance sheet, a strong cash balance of $85.7 million, and a clear strategy to scale thoughtfully, pursue selective strategic M&A, and drive sustained value for our customers and shareholders."

Industry Context

StockSavvy.ai notes that the cannabis industry continues to face pricing pressures and increased competition, as evidenced by Ascend Wellness Holdings' declining revenue despite strategic expansion. The company's focus on vertical integration, higher-margin finished goods, and an enhanced e-commerce platform aligns with broader industry trends towards optimizing operational efficiency and direct-to-consumer engagement to counter market headwinds. The expansion into social equity partner stores in New Jersey also reflects a growing industry trend towards inclusive growth and regulatory compliance.

Comparison to Industry Standards

• Ascend Wellness Holdings maintained its position among the top three brand houses by both sales and units across Illinois, Massachusetts, and New Jersey combined throughout FY 2025, indicating strong brand presence in key markets compared to competitors.
• The company's Adjusted EBITDA Margin of 23.4% for FY 2025, while showing improvement, should be benchmarked against other multi-state operators (MSOs) in the cannabis sector, which often vary widely based on market maturity, vertical integration levels, and operational scale. For example, larger MSOs like Curaleaf or Green Thumb Industries might exhibit different margin profiles due to their broader geographic reach and economies of scale.
• The sequential decline in total net revenue and wholesale revenue, coupled with ongoing pricing pressures, suggests that Ascend is navigating a challenging market environment common to many cannabis companies, where supply often outstrips demand in mature markets.

Legal Proceedings

• A $17.0 million arbitration settlement expense was recorded in Q4 2025.
• The arbitration matter was fully resolved in Q1 2026.
• Additional information regarding the matter is available in the Company's Form 8-K filed on February 13, 2026.

Stakeholder Impact

• Shareholders are impacted by declining revenue, increased net losses, and the share buyback program which retired 15.8 million shares. The strategic refinancing and focus on profitability aim to drive sustained value.
• Customers benefit from an expanded retail footprint, new product launches (566 SKUs), an enhanced e-commerce platform, AI-driven personalization, Ascend Pay functionality, and an improved loyalty program.
• Employees are affected by the closure of an underperforming store in Ann Arbor, Michigan, but also by new store openings and expansion initiatives.
• Creditors are positively impacted by the strengthening of the capital structure through debt repayment and refinancing, extending debt obligations to 2029.

Next Steps

• Begin operations for a second social equity partner store in Eatontown, New Jersey, expected in April 2026.
• Continue the full-scale brand and quality transformation of the flagship lifestyle brand Ozone in other key markets in the coming quarters.
• Launch a variety of new products in tandem with Ozone's evolution, including full-spectrum gummies, macro-dose gummies, and additional flower and vape offerings.
• Advance retail densification, enhance the retail model, and elevate the CPG platform in 2026 to drive revenue per gram and high-margin sales.
• Pursue selective strategic M&A.
• Target 60 total owned and partner-owned and operated dispensaries by the end of 2026.

Key Dates

Recommendation

While Ascend Wellness Holdings demonstrated strong operational execution in expanding its retail footprint, launching new products, and improving Adjusted EBITDA margins, the significant year-over-year revenue decline and increased net losses, coupled with a cautious Q1 2026 revenue outlook, suggest ongoing market challenges. The strategic refinancing and share buyback are positive for capital structure, but the core business faces headwinds. A "Hold" recommendation is appropriate as investors should monitor if the strategic initiatives can reverse the revenue trend and translate improved margins into sustainable profitability amidst a competitive and price-sensitive cannabis market.

Keywords

cannabis, multi-state operator, MSO, dispensary, retail, wholesale, Adjusted EBITDA, revenue, net loss, capital structure, share buyback, product launch, e-commerce, loyalty program, New Jersey, Illinois, Massachusetts, Ohio, Michigan, Pennsylvania, Maryland